Doç. Dr. Zeynep Yegin Katran

Use of omalizumab in chemotherapy rapid drug desensitization: Can anaphylaxis be prevented?

Allergy, 2023

Kaynak: ORCID

Successful Treatment of Tuberculosis Combined With Rifampicin Induced Interstitial Nephritis: A Case Report

International Journal of Nephrology and Kidney Failure, 2023

DOI 10.16966/2380-5498.235 Açık erişimli tam metinKaynak: OpenAlex

Dahili Hastalarda Özel Beslenme ve Diyet Yönetimi

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.2182 Kaynak: OpenAlex

Management of type 1 hypersensitivity reactions to antituberculosis drug: Succesful Desensitization

Research Square, 2022

DOI 10.21203/rs.3.rs-1752643/v1 Açık erişimli tam metinKaynak: ORCID

Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization

Allergy Asthma and Clinical Immunology, 2022

DOI 10.1186/s13223-022-00737-4 PMID 36414980 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Successful Oxaliplatin Desensitization After Omalizumab Administration

Research Square, 2022

DOI 10.21203/rs.3.rs-2313500/v1 Açık erişimli tam metinKaynak: ORCID

Treatment and Management of Hypersensitivity Reactions Developed Against Anti-Tuberculosis Drug

International Journal of Mycobacteriology, 2022

DOI 10.4103/ijmy.ijmy_78_22 PMID 36260451 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Tuberculosis Treatment-related Lichenoid Drug Eruptions

International Journal of Mycobacteriology, 2022

DOI 10.4103/ijmy.ijmy_151_22 PMID 36510939 Açık erişimli tam metinKaynak: ORCID

The predictive value of qSOFA and CURB-65 scores in predicting the hospitalization need and mortality in patients with acute exacerbation of chronic obstructive pulmonary disease

Italian Journal of Emergency Medicine, 2021

DOI 10.23736/s2532-1285.20.00039-7 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Follow-up of 1887 patients receiving tumor necrosis-alpha antagonists: Tuberculin skin test conversion and tuberculosis risk

The Clinical Respiratory Journal, 2018

DOI 10.1111/crj.12726 PMID 29028148 17 atıf (Europe PMC) Kaynak: ORCID